,,its beyond brutal!!!,,,,,,the teams' business plan has been so flawed over these many years it has resulted in the stagnation of the company at present. That is clearly a top to bottom management team failure of the highest order. Fastly closing in on 2 whole years of apabetalone for MACE being shelved. FDA's BTD is meaningless as the market understands the company's short comings and its inability to push validity of it's drug. I will predict that insiders will get this company for a song before any retail shareholder will get their day in the market place. And of course any entity with deep pockets do not have to use the open market to take a gambling position. We are still a flip of the coin investment! Pitiable!